Yashwitha Sai Pulakurthi
Overview
Explore the profile of Yashwitha Sai Pulakurthi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
116
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Keesari P, Samuels D, Vegivinti C, Pulakurthi Y, Kudithi R, Dhar M, et al.
Curr Hematol Malig Rep
. 2025 Jan;
20(1):3.
PMID: 39754658
Purpose Of Review: Multiple myeloma is a chronic malignancy and with evolving treatment options, understanding the economic burden and cost-effectiveness of therapies is crucial for clinicians and researchers. Recent Findings:...
2.
Keesari P, Jain A, Pulakurthi Y, Katamreddy R, Alvi A, Desai R
J Gastrointestin Liver Dis
. 2024 Sep;
33(3):386-393.
PMID: 39348575
Background And Aims: Prediabetes is often underdiagnosed and underreported due to its asymptomatic state in over 80% of individuals. Considering its role in promoting cancer incidence and limited evidence linking...
3.
Jain A, Keesari P, Pulakurthi Y, Katamreddy R, Dhar M, Desai R
Pancreas
. 2024 Sep;
54(1):e51-e56.
PMID: 39324961
Objectives: Pancreatic cancer and prediabetes pose significant public health challenges. Given the lack of strong evidence we performed a meta-analysis to assess the risk of pancreatic cancer in prediabetes. Materials...
4.
Desai R, Alvi A, Vasavada A, Pulakurthi Y, Patel B, Mohammed A, et al.
World J Cardiol
. 2024 Apr;
16(3):137-148.
PMID: 38576521
Background: Non-alcoholic fatty liver disease (NAFLD) increases cardiovascular disease (CVD) risk irrespective of other risk factors. However, large-scale cardiovascular sex and race differences are poorly understood. Aim: To investigate the...
5.
Vegivinti C, Keesari P, Veeraballi S, Martins Maia C, Mehta A, Lavu R, et al.
Exp Hematol Oncol
. 2023 Jul;
12(1):60.
PMID: 37422676
Dysregulation of the innate immune system and inflammatory-related pathways has been implicated in hematopoietic defects in the bone marrow microenvironment and associated with aging, clonal hematopoiesis, myelodysplastic syndromes (MDS), and...
6.
Jagirdhar G, Pulakurthi Y, Chigurupati H, Surani S
World J Virol
. 2023 Jul;
12(3):136-150.
PMID: 37396706
Viral gastroenteritis is the most common viral illness that affects the gastrointestinal (GI) tract, causing inflammation and irritation of the lining of the stomach and intestines. Common signs and symptoms...
7.
Hardy N, Vegivinti C, Mehta M, Thurnham J, Mebane A, Pederson J, et al.
Clin Exp Med
. 2023 Feb;
23(6):1945-1959.
PMID: 36795239
Cancer patients are more vulnerable to COVID-19 compared to the general population, but it remains unclear which types of cancer have the highest risk of COVID-19-related mortality. This study examines...
8.
Vegivinti C, Evanson K, Lyons H, Akosman I, Barrett A, Hardy N, et al.
BMC Infect Dis
. 2022 Feb;
22(1):107.
PMID: 35100985
Background: Coronavirus disease 2019 (COVID-19) continues to pose a significant threat to public health worldwide. The purpose of this study was to review current evidence obtained from randomized clinical trials...
9.
Mullangi S, Keesari P, Zaher A, Pulakurthi Y, Adusei Poku F, Rajeev A, et al.
Cureus
. 2022 Jan;
13(12):e20089.
PMID: 35003948
Background Hepatocellular Carcinoma (HCC) is a severe complication of cirrhosis and the incidence of HCC has been increasing in the United States (US). We aim to describe the trends, characteristics,...
10.
Pulakurthi Y, Pederson J, Saravu K, Gupta N, Balasubramanian P, Kamrowski S, et al.
Medicine (Baltimore)
. 2021 May;
100(20):e25719.
PMID: 34011029
Background: Corticosteroid treatment is an effective and common therapeutic strategy for various inflammatory lung pathologies and may be an effective treatment for coronavirus disease 2019 (COVID-19). The purpose of this...